Skip to main content
OpenTrials

Clinical trial condition

Neurofibrosarcoma

Explore clinical trials studying Neurofibrosarcoma. Study availability and eligibility vary by location and protocol.

72 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Neurofibrosarcoma trial results

Recruiting

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

NCT06239272

Conditions
Adipocytic Neoplasm, Angiomatoid Fibrous Histiocytoma, Angiosarcoma, +60 more
Locations
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Our Lady of the Lake Children's Hospital Baton Rouge, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of DEG6498 in Participants With Solid Tumors

NCT07244835

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +70 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

NCT05985161

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +34 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Stanford Medicine Children's Health (Data Collection Only) Palo Alto, California, United States
  • Children's National Hospital (Data Collection Only) Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta (Data Collection and Specimen Analysis) Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions
Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Grand Valley Oncology Grand Junction, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details
Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations
  • Hospital São Carlos Fortaleza, Ceará, Brazil
  • Hospital São Rafael Salvador, Estado de Bahia, Brazil
  • Hospital Santa Cruz Curitiba, Paraná, Brazil
  • IDOR Recife Recife, Pernambuco, Brazil
View Trial Details

Related conditions